Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2007 Dec 1.

Published in final edited form as: Pharmacogenomics J. 2007 Jan 2;7(6):368–379. doi: 10.1038/sj.tpj.6500430

Panel A, Schematic of the NTRK2 gene showing locations of the 24 exons, SNP marker positions, and the haplotype blocks with their approximate physical sizes. Panel B, Haploview-generated LD map of the NTRK2 region in the Finnish Caucasian control sample. The AD sample produced similar results. Regions of high LD (D′ = 1 and LOD > 2) are shown in bright red. Markers with lower LD are shown in red (with D′ value indicated as a percentage) through pink (decreasing color intensity indicates decreasing D′ value). Regions with high D′ values (= 1) but low informativeness (LOD < 2) are shown in light blue. Regions of low LD and low LOD scores (D′ < 2, LOD <2) are shown in white. Five haplotype blocks are indicated.

Panel A, Schematic of the NTRK2 gene showing locations of the 24 exons, SNP marker positions, and the haplotype blocks with their approximate physical sizes. Panel B, Haploview-generated LD map of the NTRK2 region in the Finnish Caucasian control sample. The AD sample produced similar results. Regions of high LD (D′ = 1 and LOD > 2) are shown in bright red. Markers with lower LD are shown in red (with D′ value indicated as a percentage) through pink (decreasing color intensity indicates decreasing D′ value). Regions with high D′ values (= 1) but low informativeness (LOD < 2) are shown in light blue. Regions of low LD and low LOD scores (D′ < 2, LOD <2) are shown in white. Five haplotype blocks are indicated.

HHS Vulnerability Disclosure